Barclays Has Lowered Expectations for Becton, Dickinson and Company (NYSE:BDX) Stock Price
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) had its price target lowered by Barclays from $279.00 to $261.00 in a report issued on Monday,Benzinga reports. The firm currently has an “overweight” rating on the medical instruments supplier’s stock. Barclays‘s target price would indicate a potential upside of 30.11% from the stock’s previous close. […]
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) had its price target lowered by Barclays from $279.00 to $261.00 in a report issued on Monday,Benzinga reports. The firm currently has an “overweight” rating on the medical instruments supplier’s stock. Barclays‘s target price would indicate a potential upside of 30.11% from the stock’s previous close. […]
